دورية أكاديمية
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
العنوان: | A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer |
---|---|
المؤلفون: | Day, DaphneAff1, Aff2, IDs41416023024317_cor1, Park, John J., Coward, JermaineAff4, Aff5, Markman, BenAff1, Aff2, Lemech, CharlotteAff6, Aff7, Kuo, James C.Aff6, Aff7, Prawira, AmyAff7, Aff8, Brown, Michael P.Aff9, Aff10, Bishnoi, Sarwan, Kotasek, Dusan, Strother, R. Matthew, Cosman, RashaAff7, Aff8, Su, Rila, Ma, Yiding, Yue, Zenglian, Hu, Hui-han, Wu, Rachel, Li, Peiqi, Tse, Archie N. |
المصدر: | British Journal of Cancer. 129(10):1608-1618 |
قاعدة البيانات: | Springer Nature Journals |
تدمد: | 00070920 15321827 |
---|---|
DOI: | 10.1038/s41416-023-02431-7 |